Literature DB >> 31207009

Prevention of postoperative adhesion reformation by intermittent intrauterine balloon therapy: a randomised controlled trial.

X Shi1, S H Saravelos2,3, Q Zhou1, X Huang1, E Xia1, T C Li1,3.   

Abstract

OBJECTIVE: To compare the efficacy of intermittent intrauterine balloon dilatation versus standard care in the prevention of adhesion reformation.
DESIGN: Single-blind randomised controlled trial.
SETTING: Hysteroscopic Centre of a tertiary University Hospital. POPULATION: Two hundred patients with moderate to severe (European Society for Gynaecological Endoscopy Grade ≥II) intrauterine adhesions who underwent hysteroscopic adhesiolysis.
METHODS: All participants were randomised to a balloon group or a control group postoperatively. The balloon group received intrauterine balloon dilatation therapy at 2 weeks and 6 weeks after surgery, whereas the control group did not. All patients underwent follow-up hysteroscopy at 4 and 8 weeks postoperatively. MAIN OUTCOME MEASURES: The adhesion reformation rate and the Pictorial Blood Loss Assessment Chart scores were analysed.
RESULTS: A total of 191 patients successfully completed the study protocol (94 cases for the balloon group and 97 cases for the control group). According to hysteroscopic evaluation at the 8th week, the overall adhesion reformation rate was significantly lower in patients in the balloon group than patients in the control group (20.2% versus 40.2%, respectively; P < 0.05). There was also a significant increase in menstruation flow, as assessed by the Pictorial Blood Loss Assessment Chart score (30 versus 9, respectively; P < 0.001).
CONCLUSIONS: Postoperative intermittent intrauterine balloon dilatation therapy can significantly reduce postoperative adhesion reformation and significantly increase menstruation flow. TWEETABLE ABSTRACT: RCT: Postoperative intermittent intrauterine balloon therapy can prevent adhesion reformation after hysteroscopic adhesiolysis.
© 2019 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Asherman syndrome; balloon; hysteroscopic adhesiolysis; intrauterine adhesions; recurrence

Mesh:

Year:  2019        PMID: 31207009     DOI: 10.1111/1471-0528.15843

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  Pregnancy outcome after intrauterine adhesiolysis.

Authors:  Enlan Xia; Xiaowu Huang; Tin-Chiu Li
Journal:  Ann Transl Med       Date:  2020-03

2.  Asherman syndrome: Audit of a single-operator cohort of 423 cases.

Authors:  Thierry Vancaillie; Karen Chan; Jinzhu Liu; Rebecca Deans; Elizabeth Howard
Journal:  Aust N Z J Obstet Gynaecol       Date:  2020-05-26       Impact factor: 2.100

3.  In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: A therapy for intrauterine adhesions.

Authors:  Liaobing Xin; Cheng Wei; Xiaomei Tong; Yangyang Dai; Dong Huang; Jianmin Chen; Lie Ma; Songying Zhang
Journal:  Bioact Mater       Date:  2021-10-22

4.  A Simplified Murine Model to Imitate Flexor Tendon Adhesion Formation without Suture.

Authors:  Rong Bao; Shi Cheng; Jianyu Zhu; Feng Hai; Wenli Mi; Shen Liu
Journal:  Biomimetics (Basel)       Date:  2022-07-07

Review 5.  Application of Traditional Chinese Medicines in Postoperative Abdominal Adhesion.

Authors:  Fuling Wu; Wenqin Liu; Haixing Feng; Li Long; Lianbing Hou; Chuqi Hou
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-26       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.